فصلنامه نفس

Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital based survey of aspergillosis. Clinical Infectious Diseases. 2001;33(11):1824-1833.

Hedayati MT, Mohammadpour RA. A survey on the mycological contamination of the air and the equipment of operating rooms of 17 hospitals. Journal of Medical faculty of Gilan University of Medical Sciences. 1999;8(19):56-61. (in Farsi)

Hedayati MT, Mohseni-Bandpi A, Moradi S. A survey on the pathogenic fungi in soil samples of potted plants from Sari hospitals, Iran. Journal of Hospital Infection. 2004;58:59-62.

Ader F. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. Current Infectious Disease Reports. 2010;12(6):409-416.

Hedayati MT, Khodavaisy S, Aliali M. A review on invasive aspergillosis in patients admitted to intensive care unit with emphasis on diagnostic methods. Journal of Mazandaran University of Medical Sciences. 2009;20(74):99-112. (in Farsi)

Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2008;46(3):327-360.

Ader F, Bienvenu AL, Rammaert B, Nseir S. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. International Journal of Chronic Obstructive Pulmonary Disease. 2009;4:279-287.

Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clinical Infectious Diseases. 1998;26(6):1473-1475.

Ader F, Nseir S, Le Berre R, Leroy S, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clinical Microbiology and Infection. 2005;11(6):427-429.

Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. European Respiratory Journal. 2007;30(4):782-800.

Samarakoon P, Soubani AO. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chronic Respiratory Disease. 2008;5(1):19-27.

Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clinical Infectious Diseases. 2007;45(2):205-216.

Bouza E, Guinea J, Pelaez T, Perez-Molina J, Alcala L, Munoz P. Workload due to Aspergillus fumigatus and signifcance of the organism in the microbiology laboratory of a general hospital. Journal of Clinical Microbiology. 2005;43(5):2075-2079.

Rabe KF, Hurd S, Anzuet A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine. 2007;176(6):532-555.

Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. European Respiratory Journal. 2008;31(6):1334-1356.

Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. American Journal of Medicine. 1986;81(2):249-254.

Romani L. Immunity to fungal infections. Nature Reviews Immunology. 2004;4(1):1-23.

Seidler MJ, Salvenmoser S, Müller FMC. Aspergillus fumigatus forms bioflms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrobial Agents and Chemotherapy. 2008;52(11):4130-4136.

Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. Journal of Clinical Investigation. 1985;76(5):1755-1764.

Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology. 1994;140(Pt 9):2475-2479.

Peter E, Bakri F, Ball DM, Cheney RT, Segal BH. Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy. Clinical Infectious Diseases. 2002;35(5):e54-56.

Barouky R, Badet M, Denis MS, Soubirou JL, Philit F, Guerin C. Inhaled corticosteroids in COPD and disseminated aspergillosis. European Journal of Internal Medicine. 2003;14(6):380-382.

Cornet M, Mallat H, Somme D, et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients--a two-case report. Clinical Microbiology and Infection. 2003;9(12):1224-1227.

Thommi G, Bell G, Liu J, Nugent K. Spectrum of invasive pulmonary aspergillosis in immunocompetent patients withchronic obstructive pulmonary disease. Southern Medical Journal. 1991;84(7):828-831.

Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. European Respiratory Journal. 2007;30(4):782-800.

Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore). 2000;79(4):250-260.

Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clinical Infectious Diseases. 2001;32(3):358-366.

Guinea J, Torres-Narbona M, Gijón P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clinical Microbiology and Infection. 2010;16(7):870-877.

Gao X, Chen L, Hu G, Mei H. Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests. Annals of Saudi Medicine. 2010;30(3):193-197.

Roosen J, Frans E, Wilmer A, Knockaert DC, Bobbaers H. Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings. Mayo Clinic Proceedings. 2000;75(6):562-567.

Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. Journal of Chemotherapy. 2003;15(1):71-75.

Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Critical Care. 2005;9(3):R191-199.

Collins J. CT signs and patterns of lung disease. Radiologic Clinics of North America. 2001;39(6):1115-1135.

Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. Journal of Clinical Oncology. 2001;19(1):253-259.

Vandewoude KH, Blot SI, Benoit D, Colardyn F, Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. Journal of Hospital Infection. 2004;56(4):269-276.

Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. American Journal of Clinical Pathology. 1986;86(4):518-523.

Andreas S, Heindl S, Wattky C, Möller K, Rüchel R. Diagnosis of pulmonary aspergillosis using optical brighteners. European Respiratory Journal. 2000;15(2):407-411.

Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clinical Microbiology and Infection. 2001;7 Suppl 2:54-61.

Barouky R, Badet M, Denis MS, Soubirou JL, Philit F, Guerin C. Inhaled corticosteroids in chronic obstructive pulmonary disease and disseminated aspergillosis. European Journal of Internal Medicine. 2003;14(6):380-382.

Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clinical Infectious Diseases. 2006;42(10):1417-1427.

Martínez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clinical Infectious Diseases. 2008;47(12):1526-1533.

Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. American Journal of Respiratory and Critical Care Medicine. 2004;170(6):621-625.

Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin–tazobactam. Clinical Infectious Diseases. 2004;38(6):913-916.

Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. Journal of Clinical Microbiology. 2004;42(12):5517-5522.

Seyfarth HJ, Nenoff P, Winkler J, Krahl R, Haustein UF, Schauer J. Aspergillus detection in bronchoscopically acquired material. Significance and interpretation. Mycoses. 2001;44(9-10):356-360.

Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. American Journal of Respiratory and Critical Care Medicine. 2008;177(1):27-34.

Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clinical Infectious Diseases. 2005;41(5):654-659.

Skladny H, Buchheidt D, Baust C, et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. Journal of Clinical Microbiology. 1999;37(12):3865-3871.

Mengoli C, Cruciani M, Barnes RA, Loeffer J, Donnelly P. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infectious Disesaes. 2009;9(2):89-96.

Garcia ME, Blanco JL, Caballero J, Gargallo-Viola D. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. Journal of Clinical Microbiology. 2002;40(4):1567-1568.